Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masataka Okamoto

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Cancer Science|July 22, 2006
Expression profiling analysis of the CD5+ diffuse large B-cell lymphoma subgroup: development of a CD5 signatureMiyuki Suguro, Hiroyuki Tagawa, Yoshitoyo Kagami, et al.
Histopathology|February 24, 2017
Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cellsAkiko Ohashi, Seiichi Kato, Akinao Okamoto, et al.
Internal Medicine (Tokyo, Japan)|August 19, 2009
Successful pregnancy in a patient with chronic myeloid leukemia under treatment with imatinibMotohiro Tsuzuki, Youko Inaguma, Kousuke Handa, et al.
Blood|May 12, 2005
Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphomaHiroyuki Tagawa, Miyuki Suguro, Shinobu Tsuzuki, et al.
The American Journal of Surgical Pathology|January 27, 2007
Adult T-cell lymphoma/leukemia with angioimmunoblastic T-cell lymphomalike features: Report of 11 casesKennosuke Karube, Junji Suzumiya, Masataka Okamoto, et al.
Pathology International|November 20, 2018
Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma arising in patient with a history of EBV-positive mucocutaneous ulcer and EBV-positive nodal polymorphous B-lymphoproliferative disorderTeerada Daroontum, Kei Kohno, Yoko Inaguma, et al.
Cureus|November 3, 2025
Comparison of One-Year Adverse Events Between First- and Second-Generation Bruton's Tyrosine Kinase Inhibitors: A Retrospective StudyAo Ito, Kaori Ito, Chisako Iriyama, et al.
Cytogenetic and Genome Research|June 17, 2020
Truncated RUNX1 Generated by the Fusion of RUNX1 to Antisense GRIK2 via a Cryptic Chromosome Translocation Enhances Sensitivity to Granulocyte Colony-Stimulating FactorAkihiro Abe, Yukiya Yamamoto, Akira Katsumi, et al.
International Journal of Hematology|March 31, 2015
The fate of patients with acute myeloid leukemia not undergoing induction chemotherapyMasamitsu Yanada, Akinao Okamoto, Yoko Inaguma, et al.
Cancer Chemotherapy and Pharmacology|June 22, 2016
Evaluation of a method for calculating carboplatin dosage in DeVIC ± R therapy (combination therapy of dexamethasone, etoposide, ifosfamide and carboplatin with or without rituximab) as a salvage therapy in patients with relapsed or refractory non-Hodgkin lymphomaAyana Tomono, Kaori Ito, Takahiro Hayashi, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Cancer Science|July 22, 2006
Expression profiling analysis of the CD5+ diffuse large B-cell lymphoma subgroup: development of a CD5 signatureMiyuki Suguro, Hiroyuki Tagawa, Yoshitoyo Kagami, et al.
Histopathology|February 24, 2017
Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cellsAkiko Ohashi, Seiichi Kato, Akinao Okamoto, et al.
Internal Medicine (Tokyo, Japan)|August 19, 2009
Successful pregnancy in a patient with chronic myeloid leukemia under treatment with imatinibMotohiro Tsuzuki, Youko Inaguma, Kousuke Handa, et al.
Blood|May 12, 2005
Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphomaHiroyuki Tagawa, Miyuki Suguro, Shinobu Tsuzuki, et al.
The American Journal of Surgical Pathology|January 27, 2007
Adult T-cell lymphoma/leukemia with angioimmunoblastic T-cell lymphomalike features: Report of 11 casesKennosuke Karube, Junji Suzumiya, Masataka Okamoto, et al.
Pathology International|November 20, 2018
Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma arising in patient with a history of EBV-positive mucocutaneous ulcer and EBV-positive nodal polymorphous B-lymphoproliferative disorderTeerada Daroontum, Kei Kohno, Yoko Inaguma, et al.
Cureus|November 3, 2025
Comparison of One-Year Adverse Events Between First- and Second-Generation Bruton's Tyrosine Kinase Inhibitors: A Retrospective StudyAo Ito, Kaori Ito, Chisako Iriyama, et al.
Cytogenetic and Genome Research|June 17, 2020
Truncated RUNX1 Generated by the Fusion of RUNX1 to Antisense GRIK2 via a Cryptic Chromosome Translocation Enhances Sensitivity to Granulocyte Colony-Stimulating FactorAkihiro Abe, Yukiya Yamamoto, Akira Katsumi, et al.
International Journal of Hematology|March 31, 2015
The fate of patients with acute myeloid leukemia not undergoing induction chemotherapyMasamitsu Yanada, Akinao Okamoto, Yoko Inaguma, et al.
Cancer Chemotherapy and Pharmacology|June 22, 2016
Evaluation of a method for calculating carboplatin dosage in DeVIC ± R therapy (combination therapy of dexamethasone, etoposide, ifosfamide and carboplatin with or without rituximab) as a salvage therapy in patients with relapsed or refractory non-Hodgkin lymphomaAyana Tomono, Kaori Ito, Takahiro Hayashi, et al.
Pageof 7